Table 13.
Comparisons of the selectivity index (SI) of antiviral activity on HSV-1 between prophylactic (IVR) and virucidal (DVI) at best time for MBS extract and between that of MBS extract and the standard drug (Acyclovir)
| Extract | Protocol vs Protocol | Time vs Time | SI vs SI | P value | |
|---|---|---|---|---|---|
| MBS | aIVR vs bDVI | 1 h vs 2 h | 10.9 ± 0.96 vs 18.23 ± 1.69 | 0.009 | Significant |
| MBS vs Acyclovir | aIVR vs aIVR | 1 h vs 1 h | 10.9 ± 0.96 vs 15.04 ± 1.9 | 0.06 | Non-significant |
| MBS vs Acyclovir | bDVI vs bDVI | 2 h vs 2 h | 18.23 ± 1.69 vs 22.56 ± 1.11 | 0.05 | Non- Significant |
Note: aIVR: the inhibition in virus infection after specific cell treatment. bDVI: the direct virus inactivation